A 2018 study further evaluated the efficacy of CNPY2 as a biomarker in colorectal cancer, finding that combining CNPY2 with CEA and CA19-9 significantly improved diagnostic accuracy compared to using each marker individually [55]. The gene discussed is CNPY2; the disease is colorectal cancer.